Comparison of nifekalant and amiodarone for resuscitation after cardiopulmonary arrest due to shock-resistant ventricular fibrillation

Documenti analoghi

• Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation
  di: Harayama, Nobuya, et al.
  Pubblicazione: (2014)
• Catecholamine index is a simple and useful marker for bacteremic patients treated by polymyxin B hemoperfusion therapy
  di: Isa, Y, et al.
  Pubblicazione: (2011)
• Effect of nifekalant for out-of–hospital cardiac arrest with shock-resistant ventricular fibrillation
  di: Toyama, H, et al.
  Pubblicazione: (2004)
• Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia
  di: Sato, Shiho, et al.
  Pubblicazione: (2017)
• Bacteremia affects the mortality of septic patients with high serum procalcitonin level in the ICU
  di: Kamochi, M, et al.
  Pubblicazione: (2012)